CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Other Operating Expenses (2023 - 2026)

Updated

CytoMed Therapeutics (GDTC) reported Other Operating Expenses of -$1.67 million for FY2025, compared with -$998,054 in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Other Operating Expenses (2023 - 2026) Analysis & Trends

Dating back to FY2020, CytoMed Therapeutics' Other Operating Expenses record includes 6 years.

  • Five-year annual Other Operating Expenses spans a low of -$2.21 million in FY2023 and a high of -$494,675 in FY2022.
  • According to Business Quant data, Other Operating Expenses came in at -$998,054 in FY2024, -$2.21 million in FY2023, -$494,675 in FY2022 and -$518,766 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,742.00
Jun 30, 2025 195,517.00
Jun 30, 2024 180,749.00
Jun 30, 2023 59,611.00
API Access

CytoMed Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GDTC&period=max&api_key=YOUR_API_KEY